2024-09-11 Sale |
2024-09-13 6:54 pm |
Skye Bioscience Inc. |
SKYE |
5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner |
266,337 |
$6.5719 |
$1,750,352 |
66,277 (Indirect) |
View |
2024-03-13 Purchase |
2024-03-15 4:15 pm |
Skye Bioscience Inc. |
SKYE |
5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner |
450,000 |
$10 |
$4,500,000 |
10,179,505 (Indirect) |
View |
2024-01-31 Purchase |
2024-02-02 4:32 pm |
Skye Bioscience Inc. |
SKYE |
5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner |
5,206,074 |
$2.31 |
$12,026,031 |
9,729,505 (Indirect) |
View |
2023-04-10 Sale |
2023-04-12 4:51 pm |
Pear Therapeutics Inc. |
PEAR |
5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
16,544,113 |
$0.12 |
$1,985,294 |
200,000 (Indirect) |
View |
2023-03-07 Sale |
2023-03-09 4:35 pm |
Rallybio Corp |
RLYB |
5AM Partners V LLC Schwab Andrew J. 5AM Ventures V L.P. ROCKLAGE SCOTT M 10% Owner |
100,000 |
$8.2 |
$820,000 |
3,630,724 (Indirect) |
View |
2022-11-11 Sale |
2022-11-15 8:32 pm |
Pear Therapeutics Inc. |
PEAR |
5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
105,281 |
$2.7381 |
$288,267 |
3,907,624 (Indirect) |
View |
2022-10-31 Sale |
2022-11-02 7:49 pm |
Pear Therapeutics Inc. |
PEAR |
5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
54,209 |
$2.7688 |
$150,096 |
3,911,835 (Indirect) |
View |
2022-10-06 Sale |
2022-10-11 7:10 pm |
scPharmaceuticals Inc. |
SCPH |
5AM Partners IV LLC 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Ventures IV L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
600,000 |
$4.1482 |
$2,488,907 |
410,268 (Indirect) |
View |
2022-09-14 Sale |
2022-09-16 6:03 pm |
Pear Therapeutics Inc. |
PEAR |
5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
558,168 |
$1.8764 |
$1,047,322 |
3,914,004 (Indirect) |
View |
2022-09-06 Sale |
2022-09-08 8:01 pm |
Pear Therapeutics Inc. |
PEAR |
5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
770,000 |
$2.0543 |
$1,581,835 |
3,936,331 (Indirect) |
View |
2022-09-06 Sale |
2022-09-08 7:58 pm |
scPharmaceuticals Inc. |
SCPH |
5AM Partners IV LLC 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Ventures IV L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
226,622 |
$4.8405 |
$1,096,953 |
503,112 (Indirect) |
View |
2022-08-16 Sale |
2022-08-18 8:05 pm |
Pear Therapeutics Inc. |
PEAR |
5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
400,000 |
$1.6501 |
$660,060 |
3,967,131 (Indirect) |
View |
2022-06-03 Sale |
2022-06-07 5:02 pm |
Rallybio Corp |
RLYB |
5AM Opportunities I L.P. Schwab Andrew J. 5AM Opportunities I (GP) LLC 5AM Partners V LLC 5AM Ventures V L.P. ROCKLAGE SCOTT M 10% Owner |
150,000 |
$12.5 |
$1,875,000 |
2,478,969 (Indirect) |
View |
2022-05-23 Sale |
2022-05-25 6:31 pm |
Rallybio Corp |
RLYB |
5AM Opportunities I L.P. Schwab Andrew J. 5AM Opportunities I (GP) LLC 5AM Partners V LLC 5AM Ventures V L.P. ROCKLAGE SCOTT M 10% Owner |
100,000 |
$13 |
$1,300,000 |
2,578,640 (Indirect) |
View |
2022-04-11 Sale |
2022-04-13 4:51 pm |
scPharmaceuticals Inc. |
SCPH |
5AM Partners IV LLC 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Ventures IV L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
270,000 |
$5 |
$1,350,000 |
537,301 (Indirect) |
View |
2022-02-08 Sale |
2022-02-10 6:24 pm |
Rallybio Corp |
RLYB |
5AM Opportunities I L.P. Schwab Andrew J. 5AM Opportunities I (GP) LLC 5AM Partners V LLC 5AM Ventures V L.P. ROCKLAGE SCOTT M 10% Owner |
210,000 |
$13.05 |
$2,740,500 |
2,645,087 (Indirect) |
View |
2021-11-02 Purchase |
2021-11-04 9:10 pm |
Entrada Therapeutics Inc. |
TRDA |
5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
250,000 |
$20 |
$5,000,000 |
1,132,357 (Indirect) |
View |
2021-11-01 Sale |
2021-11-03 4:38 pm |
Cabaletta Bio Inc. |
CABA |
5AM Ventures V L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
295,000 |
$13 |
$3,835,000 |
333,144 (Indirect) |
View |
2021-09-07 Sale |
2021-09-09 5:34 pm |
Cabaletta Bio Inc. |
CABA |
5AM Ventures V L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
625,000 |
$9.7 |
$6,062,500 |
2,359,263 (Indirect) |
View |
2021-08-02 Purchase |
2021-08-04 9:17 pm |
Rallybio Corp |
RLYB |
5AM Opportunities I L.P. Schwab Andrew J. 5AM Opportunities I (GP) LLC 5AM Partners V LLC 5AM Ventures V L.P. ROCKLAGE SCOTT M 10% Owner |
615,384 |
$13 |
$7,999,992 |
4,190,724 (Indirect) |
View |
2021-04-27 Purchase |
2021-04-29 8:51 pm |
IMPEL NEUROPHARMA INC |
IMPL |
5AM Ventures V L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC 10% Owner |
575,000 |
$15 |
$8,625,000 |
575,000 (Indirect) |
View |
2021-01-08 Sale |
2021-01-12 5:07 pm |
Cabaletta Bio Inc. |
CABA |
5AM Ventures V L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
387,000 |
$13 |
$5,031,000 |
369,688 (Indirect) |
View |
2020-12-29 Sale |
2020-12-31 9:31 pm |
Akouos Inc. |
AKUS |
5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
470,000 |
$18 |
$8,460,000 |
982,453 (Indirect) |
View |
2020-12-22 Sale |
2020-12-28 9:35 pm |
Homology Medicines Inc. |
FIXX |
5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
500,000 |
$12.82 |
$6,410,000 |
181,435 (Indirect) |
View |
2020-12-14 Sale |
2020-12-16 7:15 pm |
Homology Medicines Inc. |
FIXX |
5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
500,000 |
$12.25 |
$6,125,915 |
201,435 (Indirect) |
View |
2020-12-10 Sale |
2020-12-14 5:58 pm |
Cabaletta Bio Inc. |
CABA |
5AM Ventures V L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Partners V LLC PARMAR KUSH ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
298,000 |
$14.75 |
$4,395,500 |
417,629 (Indirect) |
View |
2020-11-11 Sale |
2020-11-13 8:53 pm |
IDEAYA Biosciences Inc. |
IDYA |
5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC DIEKMAN JOHN D Schwab Andrew J. ROCKLAGE SCOTT M Former 10% holder 10% Owner |
800,000 |
$13.66 |
$10,928,000 |
384,496 (Indirect) |
View |
2020-10-05 Sale |
2020-10-07 9:30 pm |
Aprea Therapeutics Inc. |
APRE |
5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC DIEKMAN JOHN D Schwab Andrew J. PARMAR KUSH ROCKLAGE SCOTT M Former 10% holder |
175,000 |
$25.3 |
$4,427,500 |
2,037,654 (Indirect) |
View |
2020-06-30 Purchase |
2020-07-02 8:50 pm |
Akouos Inc. |
AKUS |
5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
294,117 |
$17 |
$4,999,989 |
1,094,101 (Indirect) |
View |
2020-06-16 Sale |
2020-06-18 7:23 pm |
Aprea Therapeutics Inc. |
APRE |
ROCKLAGE SCOTT M Director 10% Owner |
120,164 |
$33.3 |
$4,001,461 |
75,965 (Indirect) |
View |